Search filters

List of works by Taina Turpeenniemi-Hujanen

2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

scientific article published on 4 January 2013

A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53

scientific article published on February 21, 2011

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

scientific article

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

scientific article published on 21 February 2015

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer

scientific article

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.

scientific article published on 24 May 2016

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

scientific article published on 13 September 2011

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure

scientific article published on 15 January 2013

Combination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinoma

scientific article published on January 2013

Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma

scientific article published on 9 January 2008

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study

scientific article

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer

scientific article

Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

scientific article published on 19 January 2009

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial

scientific article published on 01 September 2018

Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial

scientific article published on 2 November 2009

Generalisability of survival estimates for patients with breast cancer – A comparison across two population-based series

article

Long-term prognosis of breast cancer detected by mammography screening or other methods

scientific article published on 28 December 2011

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

scientific article published on July 2008

Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

scientific article published on 17 October 2016

Snail promotes an invasive phenotype in lung carcinoma

scientific article published on November 17, 2012

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study

scientific article published on April 22, 2011

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma

scientific article

Very high quantitative tumor HER2 content and outcome in early breast cancer

scientific article published on 01 February 2011

p53 in head and neck cancer: Functional consequences and environmental implications of TP53mutations

scientific article published on December 15, 2010